PKD
Parkd Ltd
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Parkd Ltd. engages in the development of lightweight concrete modular car parking system. The company is headquartered in Perth, Western Australia. The company went IPO on 2017-12-06. The firm is engaged in the design and construction of modular car parks and further development of modular car parking systems. The company has created a modular, multi-storey carpark structure called the PARKD Car Park System. The PARKD Car Park System is designed for single or multi rise arrangements of up to six levels, including ground level. The company offers a turnkey design and construction service for car parking structures from concept to handover of a completed car park structure. The company provides advice on the layout and arrangement of car parks to suit both greenfield and brownfield sites. The company offers various delivery methods for its system, such as develop, design and construction; conforming design and construction to an existing structural/architectural arrangement; design and assembly of the system in partnership with a head contractor or builder; and design and supply of the system in partnership with a head contractor or builder.
📈 Performance
Price History
-84.00%
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.03
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in PKD
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in PKD
N/A
PKD investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in PKD also invest in...
Want more shares? Try these...
Peako Ltd. engages in exploration and development of mineral properties. The company is headquartered in Melbourne, Victoria. The company went IPO on 2009-12-02. The firm is primarily focused on its flagship East Kimberley Project in Western Australia. The firm's projects include East Kimberley Project and Broadhurst (Sunday Creek) Project. The East Kimberley Project is located in the Halls Creek Orogen near the southern margin of the Kimberley Basin, Western Australia (WA). The project covers approximately 4,029 square kilometers of tenements. The Broadhurst (Sunday Creek) Project tenement is in the Rudall River area of the Paterson province of Western Australia. This project also has three applications for exploration licenses located close to its Broadhurst Project tenement. The Broadhurst Projects tenement area is largely carbonaceous shales and siltstones of the Broadhurst formation, and lesser quartz sandstone and siltstone of the underlying Coolbro sandstone formation. Its Eastman Intrusion is an underexplored intrusive complex that is prospective for PGE resources.
📊 Share price
$0.01 AUD
Proteomics International Laboratories Ltd. is a medical technology company which operates at the forefront of predictive diagnostics and bio-analytical services. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2015-04-16. The firm is engaged in predictive diagnostics and bio-analytical services. The firm specializes in proteomics, the study of the structure and function of proteins. The firm focuses on developing and commercializing diagnostic tests for chronic diseases. The firm operates in three business units unified by a technology platform: PromarkerD, Diagnostics and Analytical Services. The PromarkerD test system is a blood test that assess the risk of diabetic kidney disease (DKD) in patients with type 2 diabetes. Diagnostics includes Promarker platform, used to discover, verify, and analytically validate the panel of protein biomarkers for diabetic kidney disease. Its Analytical Services includes a proteomics-based technology platform, used to test, and validate the protein composition of a wide and varied range of products.
📊 Share price
